Cyclophosphamide. Cyclophosphamide (Cytoxan), an immunosuppressive agent, may be effective for preventing lung deterioration and is the important agent for treating pulmonary fibrosis. Cyclophosphamide, available in forms that are intravenous and taken by mouth, blocks some of the destructive actions of scleroderma in the lung. Intravenous cyclophosphamide can be life-saving for patients with pneumonia resulting from interstitial lung disease. Si...
Read more »Probably one of the biggest issues faced by people with COPD is loss; the loss of their former... Read more »
K. Waheed of Virginia started having flashbacks when she was in her twenties. Her “persistent,... Read more »
Diabetes is not one disease and different types of diabetes have been identified in the scientific... Read more »
After six years of work and a budget of $33 million, the Sequences Treatment Alternatives to... Read more »
As asthma affects about 6% of the U.S. population, there is a need to provide guidelines to... Read more »
(Ivanhoe Newswire) -- New insight into ancient bacteria may spur the development of a novel cystic fibrosis (CF) treatment. People who have CF suffer... Read summary »
(Ivanhoe Newswire) -- There are a few endurance athletes for whom regular athletic training will increase the risk of cardiac arrhythmias and even... Read summary »
(Ivanhoe Newswire) -- A promising drug for treatment of colorectal cancer may not be effective in 40 percent of patients with the cancer, new... Read summary »
(Ivanhoe Newswire) -- An antioxidant contained in nutritional supplements often used by body builders has been linked to a serious respiratory... Read summary »
(Ivanhoe Newswire) -- A combination of two chemotherapy regimens may be a viable alternative to current treatments for non-small cell lung cancer. A... Read summary »